Which just goes to show the irrationality of the s
Post# of 148179
Between February of 2017 and July 2018 MTNB went from $3.74 to .35 cents a share.
MAT9001 has done very little so far so I don't expect much from the new trial either. The deal they set up is very unproductive if they don't hit milestones. Where do you think MTNB will be a year from now versus Cytodyn?